Related Experiment Video
Updated: Jun 3, 2025
05:19
Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
Published on: July 7, 2023
2.2K
Depression Treatment: Is There a Role for Botulinum Toxin Type A?
Carmen Rodríguez-Cerdeira1,2,3, Westley Eckhardt1
1Department of University Program for Seniors, University of Vigo, E.E. Industrial Rúa Torrecedeira 86, Vigo Campus, 36201 Vigo, Spain.
Microorganisms
|January 8, 2025
Summary
Botulinum toxin type A injections targeting facial muscles may offer antidepressant effects for depression patients. This treatment influences facial feedback, potentially improving mood states by relaxing specific facial muscles.
Area of Science:
- Neurology
- Psychiatry
- Dermatology
Background:
- Facial expressions are linked to mood regulation.
- The role of facial muscle feedback in mental health is an emerging area of research.
Purpose of the Study:
- To review existing studies on the antidepressant effects of botulinum toxin type A.
- To investigate the impact of botulinum toxin type A on mood in patients with depression.
Main Methods:
- Systematic review of studies examining botulinum toxin type A and depression.
- Analysis of research on the connection between facial muscle activity and emotional states.
Main Results:
- Studies indicate that facial expression muscles provide positive feedback to the brain, enhancing mood.
- Botulinum toxin type A, when applied to the corrugator and procerus muscles, demonstrates antidepressant effects.
Conclusions:
- Targeting specific facial muscles with botulinum toxin type A shows promise as an adjunct therapy for depression.
- The mechanism involves modulating facial feedback loops that influence emotional processing.
Related Concept Videos
01:23Antidepressant Drugs: MAOIs and Other Agents
192
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
192
01:26Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
653
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
653
01:25Antidepressant Drugs: Overview
356
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
356
01:30Electroconvulsive Therapy
22
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
22
01:18Depression: Overview
213
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
213
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
299
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
299